Manufacturer record

J.B. Remedies Pvt. Ltd: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

1 batch manufactured by J.B. Remedies Pvt. Ltd (Uttarakhand) was declared Not of Standard Quality in March 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: JBT-4315, Ofloxacin and Ornidazole Tablets IP. (Offlent- OZ) (exp Mar 2025). RDTL Guwahati (state lab) found it not of standard quality: Dissolution of Ofloxacin and Ornidazole. Listed in the March 2024 alert.

Records by type

1 record linked to J.B. Remedies Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
1Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Mar 2024 to Mar 2024

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

1
NSQ batches since 2024
1
Products affected
Dissolution
Most common failure
Mar 2024
Latest alert

Flagged batches per year

2024 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Ofloxacin and Ornidazole Tablets IP. (Offlent- OZ) Batch JBT-4315Mfg Apr 2023 · Exp Mar 2025 Dissolution of Ofloxacin and OrnidazoleDissolution RDTL GuwahatiState lab Mar 2024

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.